The first-ever human trial exploring the use of stem cell therapy to reverse hearing loss is about to be under way. Conducted ...

Dr Peter Ochungo, says the commonest causes of hearing loss include exposure to very loud noises, trauma to the head or ear, ...

Hearing loss is one of the world’s most prevalent chronic conditions, affecting people of all ages. It interferes with how we ...

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.

A large-scale cohort study led by researchers from Tianjin University, Shenyang Medical College, Shengjing Hospital of China ...

1 July 2025 First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Children with congenital or early-onset sensorineural hearing loss are at risk of additional neurodevelopmental disorders, including visual, cognitive and motor impairments. Systematic assessment and ...

The University of Sheffield is set to conduct the first-ever human trial using stem cell therapy, Rincell-1, to reverse sensorineural hearing loss.

Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions ...

My age is 73, and I’ve had a steadily increasing PSA level for many years. In 2020, the result was 11.8 ng/mL, and it has risen to ...

Find the latest Lineage Cell Therapeutics, Inc. (LCTX) stock quote, history, news and other vital information to help you with your stock trading and investing.